Apoquel Chewable Tablets 16mg

Fast, effective allergic itch treatment – All the same benefits as original Apoquel, but now in a palatable chew! Short-and-long-term management of allergic itch. Suitable to use , with or without food, may make for easier dosing for pet owners.

Active ingredient: Oclacitinib

10 blisters of 10 tablets

Availability: In stock

SKU: 167194

Ideal for use during the work-up as you diagnose the underlying cause
Rapid itch control provides relief while you rule out parasites and infection
A short half-life lets you stop and start itch control during the work-up

For dogs ≥ 12 months of age

Overview

Ideal for use during the work-up as you diagnose the underlying cause
Rapid itch control provides relief while you rule out parasites and infection
A short half-life lets you stop and start itch control during the work-up

For dogs ≥ 12 months of age

Customers who bought this item also bought

Bravecto - 250mg - Single

118634

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs.

Last up 12 weeks.

The following tablet strengths are:
Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg)
Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg)
Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg)
Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg)
Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Bravecto - 500mg - Single

118644

Rispoval IBR Marker Live - 20ml

102331

For the active immunisation of cattle against Infectious Bovine Rhinotracheitis (IBR), to reduce virus shedding and clinical signs including, in female cattle, abortions associated with BHV-1 infection. A reduction in abortions associated with BHV-1 infection has been demonstrated during the second trimester of gestation following challenge 28 days after vaccination.

Onset of immunity: 4 weeks (at the latest) after completion of the primary course of vaccination, as demonstrated by challenge.

Duration of immunity: 6 months.

NOTE: This is the Live vaccine.

Dosage & Administration
2 ml reconstituted vaccine.

Route:
Intranasal and/or intramuscular inoculation. The vaccine must be administered aseptically via the intramuscular route (2 ml) or sprayed into the nostrils (1 ml per nostril during aspiration) with the intranasal applicator.

Rispoval RS P13 Intranasal - 10ml

107301

For active immunisation of maternally derived antibody positive or negative calves from 9 days of age against BRSV and PI3V, to reduce the mean titre and duration of excretion of both viruses.

Onset of immunity: 5 days for BRSV and 10 days for PI3V after a single vaccination.

Duration of protective immunity: 12 weeks following a single dose. The duration of protective immunity against the PI3V fraction may be reduced in MDA positive calves vaccinated before 3 weeks of age.

Dosage & Administration
A single dose of 2ml of reconstituted vaccine should be given intranasally using the intranasal applicators provided to cattle from the age of 9 days. It is recommended to change applicators between animals to avoid transmitting infectious organisms.